This is a summary and does NOT have all possible information about "lorazepam sublingual" product. This information does not assure that this product is safe, effective, or appropriate for que. This information is not individual medical advice and does not substitute for the advice of your health care professional.

Que es el lorazepam sublingual

Lorazepam 1mg Tablets are blue, capsule-shaped tablets, measuring approximately 4 x 8mm, plain on one face and 'gp' breakbar '19' on the other. Chronic use not recommended little is known of the long term safety and efficacy; potential for dependence—see section 4. Lower doses may be sufficient in these patients See section 4. Use in patients with severe hepatic insufficiency is contraindicated.

Benzodiazepines should not be used alone in depression or anxiety with depression may precipitate suicide. Patients should be advised that since their tolerance for alcohol and other CNS depressants will be diminished in the presence of Lorazepam, these substances should either be avoided or taken in reduced dosage. Due to the potential adverse reactions including ataxia, muscle weakness, dizziness, drowsiness and fatigue see Section 4.

As a result, caution should be exercised particularly when getting up at night. Lorazepam sublingual elderly should receive sublingual reduced dose see section 4. Lorazepam is not intended for the que treatment of psychotic illness or depressive disorders, and should not be used alone to treat depressed patients.

The use of benzodiazepines may have a disinhibiting effect and may release suicidal tendencies in depressed patients. Therefore, large quantities of Lorazepam should not be prescribed to these patients. The use of benzodiazepines may taking xanax for chest pain to physical and psychological dependence.

The risk of dependence alprazolam + herbal interactions Lorazepam is low when used at the recommended dose and duration, but increases with higher doses and longer-term use. The risk of dependence is further increased in patients with a history "que" alcoholism or drug abuse, or in patients with significant personality disorders.

Therefore, use in individuals with a history of alcoholism or drug abuse should be avoided. Dependence may lead to withdrawal symptoms, especially if treatment is discontinued abruptly. Therefore, the drug should always be discontinued gradually. It may be useful to inform the patient that treatment will be of limited duration and that it will be que gradually. The patient should also be made aware of the possibility of "rebound" phenomena to minimise anxiety should they occur.

Some loss of efficacy to the hypnotic effects of short-acting benzodiazepines may develop after repeated use for a few weeks. Anxiety or insomnia may be a symptom of several other disorders. The lorazepam should be considered that the complaint may be related to an underlying physical or psychiatric disorder for which there is more specific treatment.

Patients with impaired renal or hepatic function average dose of phentermine be monitored lorazepam sublingual and have their dosage adjusted carefully according to patient response. Lower doses may be sufficient in these patients. The same precautions apply to elderly or debilitated patients and patients with chronic respiratory insufficiency.

As with all CNS-depressants, the use of benzodiazepines may precipitate encephalopathy in patients with severe hepatic insufficiency. Therefore, use in these patients is contraindicated. Some patients taking benzodiazepines have developed a blood dyscrasia, and some have had elevations in liver enzymes. Periodic haematology and liver-function assessments are recommended where repeated courses of treatment are considered clinically necessary.

Transient anterograde amnesia or memory impairment has been reported in association with the use of benzodiazepines. This effect may be advantageous when Lorazepam is used as a premedicant. However, if Lorazepam is used for insomnia due to anxiety, patients que ensure that they will be sublingual to have a period of uninterrupted sleep which is sufficient to allow dissipation of drug effect e. Paradoxical reactions have been occasionally reported during benzodiazepine use.

Such reactions may be more likely to occur in children and the elderly. Should these occur, use of the drug should be discontinued see Undesirable effects. Although hypotension has occurred only rarely, benzodiazepines should be administered is alprazolam a dangerous drug caution to patients in whom a drop in blood pressure might lead to cardiovascular or cerebrovascular complications.

This is particularly important in elderly patients. Concomitant use of lorazepam and opioids may result in sedation, respiratory depression, coma and death. Because of these risks, concomitant prescribing of sedative medicines such as benzodiazepines or related drugs such as lorazepam with opioids should be reserved for patients lorazepam sublingual whom alternative treatment options are not possible. If a decision is made to prescribe lorazepam concomitantly with opioids, the lowest effective dose should be used, and the duration of treatment should be as can xanax help with high blood pressure as possible see also general dose recommendation in section 4.

The patients should be followed closely for signs and symptoms of respiratory depression and sedation. In this respect, it is strongly recommended to inform patients and their caregivers where applicable to be aware of these how long does withdrawal from lorazepam last see section 4. Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine.

The concomitant use of sedative medicines such as benzodiazepines or related drugs such as lorazepam with opioids increases the risk of sedation, respiratory depression, coma and death "sublingual" can klonopin withdrawal cause fatigue additive CNS depressant effect. The dosage and duration of concomitant use should be limited see section 4. Enhancement of the central lorazepam sublingual effect may occur if lorazepam is combined with drugs such as neuroleptics, antipsychotics, tranquillisers, antidepressants, hypnotics, analgesics, anaesthetics, barbiturates and sedative antihistamines.

The elderly may require special supervision. Pharmacokinetic studies on potential sublingual between benzodiazepines and antiepileptic drugs have produced conflicting results. Both depression and el lorazepam sublingual que es of drug levels, as well as no change have been reported. Phenobarbital taken concomitantly may result in an additive CNS effect. Special care should be taken in adjusting the dose in the initial max xanax dosage per day of treatment.

Valproate may inhibit the glucuronidation of lorazepam increased serum levels: Reports of marked sedation, excessive salivation, hypotension, ataxia, delirium and respiratory arrest when given concurrently with lorazepam. When taken with muscle relaxants, the overall wordt je moe van tramadol effect may be increased accumulative therefore caution is advised, especially in elderly patients and at higher doses risk of falling, see Section 4.

Cisapride, lofexidine, nabilone, disulfiram and the muscle relaxants — baclofen and tizanidine. Itraconazole, ketoconazole and to a lesser extent fluconazole and voriconazole are potent inhibitors of the cytochrome P isoenzyme CYP3A4 and may increase plasma levels of benzodiazepines. The effects of benzodiazepines may be increased and prolonged by concomitant use. A dose reduction of the benzodiazepine may be required. Antihypertensives, vasodilators and diuretics: Enhanced hypotensive sublingual with ACE-inhibitors, alpha-blockers, angiotensin-II receptor antagonists, calcium channel blockers, adrenergic neurone blockers, beta-blockers, moxonidine, nitrates, hydralazine, minoxidil, sodium nitroprusside and diuretics.

Inhibition of CYP3A4 may increase the plasma sublingual of lorazepam possible increased sedation and amnesia. This interaction may be of little significance in healthy individuals, but it is not buy phentermine overnight delivery if other factors such as old age sublingual liver cirrhosis increase the risk of adverse events with concurrent use.

Benzodiazepines should not be used during pregnancy, especially during the first and last trimesters. Benzodiazepines may cause foetal damage when administered to pregnant women. If the drug is prescribed to a woman of childbearing potential, she should be tramadol a pain killer to contact her physician about stopping the drug if she intends to become, or suspects that she is, pregnant. There is a possibility that infants born to mothers who que benzodiazepines chronically during the later stages of pregnancy may develop physical dependence.

Infants of mothers who ingested benzodiazepines for several weeks or more preceding delivery have been reported to have withdrawal symptoms during the postnatal period. Symptoms lorazepam sublingual as hypoactivity, hypotonia, hypothermia, respiratory depression, apnoea, feeding problems, and impaired metabolic response to cold stress have been reported in neonates born of mothers who have received benzodiazepines during the late phase of pregnancy or at delivery.

Lorazepam is excreted in small amounts in breast milk. Mothers who lorazepam sublingual breast-feeding should not take benzodiazepines. Sedation and inability to suckle have occurred in neonates of lactating mothers taking benzodiazepines. Patients should be advised that sedation, amnesia, impaired concentration, dizziness, blurred vision and impaired muscular function may occur and that, if affected, they should not drive or to use machines, or take part in other activities where this would put themselves or others at risk.

If insufficient sleep duration occurs, the likelihood of impaired alertness may be increased. Concurrent medication may increase these effects see section 4. This medicine can impair cognitive function and can affect a patient's ability to drive safely. This class of medicine is in the list of drugs included in regulations under 5a of the Road Traffic Act When prescribing this medicine, patients should be told:. Adverse reactions, when they occur, are usually observed at the beginning of therapy and generally decrease in severity or disappear with continued use or upon decreasing the dose.

Most frequently reported adverse reactions associated with benzodiazepines include daytime drowsiness, dizziness, muscle weakness, and ataxia. Confusion, depression and unmasking of depression, numbed emotions, disinhibition, euphoria, appetite changes, sleep disturbance, change in libido, decreased orgasm. Paradoxical el que lorazepam sublingual es such as restlessness, agitation, irritability, aggressiveness, delusion, rage, insomnia, nightmares, hallucinations, psychoses, sexual arousal, and inappropriate behaviour have been occasionally reported during use.

Apnoea, worsening of sleep apnoea, worsening of obstructive pulmonary disease. Alprazolam white round pill 250 depression see 4. Abnormal liver function test values increases in bilirubin, transaminases, alkaline phosphatisejaundice. These symptoms may be difficult to distinguish from the original symptoms for which the drug was prescribed. In severe cases the following symptoms may occur: Convulsions may be more common in patients with pre-existing seizure disorders or who are taking other drugs that lower the convulsive threshold such as antidepressants.

Reporting suspected adverse reactions after authorisation of the medicinal product is important. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: In the management of overdose with any drug, it should be borne in mind that multiple agents may have been taken. Overdose of benzodiazepines is usually manifested by degrees of central nervous system depression ranging from drowsiness to coma.

In mild cases, symptoms include drowsiness, mental confusion, and lethargy. In more serious cases, and especially when other CNS-depressant drugs or alcohol sublingual ingested, symptoms may include ataxia, hypotension, hypotonia, es sublingual que el lorazepam depression, coma, and very rarely, death. If there is no advantage in emptying the stomach, activated charcoal may be effective in reducing absorption.

Hypotension, though unlikely, may be controlled with noradrenaline. Lorazepam is poorly dialysable. Que benzodiazepine antagonist, flumazenil may be useful "sublingual" hospitalised patients for the management lorazepam sublingual benzodiazepine overdose. Flumazenil product information should be consulted lorazepam sublingual to use.